» Articles » PMID: 27682885

Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)

Overview
Journal Circulation
Date 2016 Sep 30
PMID 27682885
Citations 240
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The accurate assessment of individual risk can be of great value to guiding and facilitating the prevention of atherosclerotic cardiovascular disease (ASCVD). However, prediction models in common use were formulated primarily in white populations. The China-PAR project (Prediction for ASCVD Risk in China) is aimed at developing and validating 10-year risk prediction equations for ASCVD from 4 contemporary Chinese cohorts.

Methods: Two prospective studies followed up together with a unified protocol were used as the derivation cohort to develop 10-year ASCVD risk equations in 21 320 Chinese participants. The external validation was evaluated in 2 independent Chinese cohorts with 14 123 and 70 838 participants. Furthermore, model performance was compared with the Pooled Cohort Equations reported in the American College of Cardiology/American Heart Association guideline.

Results: Over 12 years of follow-up in the derivation cohort with 21 320 Chinese participants, 1048 subjects developed a first ASCVD event. Sex-specific equations had C statistics of 0.794 (95% confidence interval, 0.775-0.814) for men and 0.811 (95% confidence interval, 0.787-0.835) for women. The predicted rates were similar to the observed rates, as indicated by a calibration χ of 13.1 for men (P=0.16) and 12.8 for women (P=0.17). Good internal and external validations of our equations were achieved in subsequent analyses. Compared with the Chinese equations, the Pooled Cohort Equations had lower C statistics and much higher calibration χ values in men.

Conclusions: Our project developed effective tools with good performance for 10-year ASCVD risk prediction among a Chinese population that will help to improve the primary prevention and management of cardiovascular disease.

Citing Articles

Precision Medicine in Cardiovascular Disease Prevention: Clinical Validation of Multi-Ancestry Polygenic Risk Scores in a U.S. Cohort.

Ponikowska M, Di Domenico P, Bolli A, Busby G, Perez E, Botta G Nutrients. 2025; 17(5).

PMID: 40077796 PMC: 11901995. DOI: 10.3390/nu17050926.


The Association of the Metabolic Score for Insulin Resistance (METS-IR) with Prehypertension in Normoglycemic Individuals.

Alogaili M, Alsallami A Int J Endocrinol Metab. 2025; 22(2):e145894.

PMID: 40071249 PMC: 11892513. DOI: 10.5812/ijem-145894.


Lipoprotein(a) molar concentrations rather than genetic variants better predict coronary artery disease risk and severity in Han Chinese population.

Li J, Ma B, Fang Q, Wang J, Sun Y, Ding H Lipids Health Dis. 2025; 24(1):49.

PMID: 39953584 PMC: 11827131. DOI: 10.1186/s12944-025-02467-z.


Development and validation of a predictive model for carotid atherosclerosis in postmenopausal women.

Liu J, Zeng X, Ruan J, Kang Y, Lu Y, Li S Sci Rep. 2025; 15(1):5079.

PMID: 39934244 PMC: 11814320. DOI: 10.1038/s41598-025-89098-7.


Predicting cardiovascular outcomes in Chinese patients with type 2 diabetes by combining risk factor trajectories and machine learning algorithm: a cohort study.

Huang Q, Zou X, Lian Z, Zhou X, Han X, Luo Y Cardiovasc Diabetol. 2025; 24(1):61.

PMID: 39920715 PMC: 11806858. DOI: 10.1186/s12933-025-02611-0.